StockWatch
·

Symbiox Investment & Trading Company Ltd

BSE: 539278

values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
-0.590.251.101.95Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Margin Trend

percentage
OPM %NPM %
-44.20-11.1621.8854.92Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
PeriodQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25
INCOME
Revenue0.26-69.1%0.83+862.0%0.09-62.9%0.23-49.5%0.46-63.2%1.25+173.6%0.46-39.5%0.75
Other Income0.000.00-100.0%0.000.00-100.0%0.00-51.3%0.00——
Total Income0.26-69.1%0.83+857.5%0.09-62.7%0.23-49.7%0.46-63.2%1.25+174.5%0.46-39.5%0.75
EXPENSES
Expenditure0.15-81.4%0.81+1061.6%0.07-53.2%0.15-59.6%0.37-77.6%1.65+586.1%0.24-22.0%0.31
Tax0.03+532.6%0.00+0.0%0.00-79.9%0.02-8.9%0.02+122.3%-0.11-287.9%0.06-51.3%0.12
PROFIT
PBT0.10+533.3%0.02-0.6%0.02-79.8%0.08-9.0%0.09+122.3%-0.40-289.1%0.21-51.6%0.44
Net Profit0.08+533.6%0.01-0.8%0.01-79.8%0.06-9.0%0.07+122.3%-0.30-288.3%0.16-51.4%0.33
KEY METRICS
OPM %41.21%+39.13pp2.08%-17.57pp19.65%-16.20pp35.85%+16.38pp19.47%+52.23pp-32.76%——
NPM %30.28%+28.81pp1.47%-12.77pp14.24%-12.07pp26.31%+11.77pp14.54%+38.51pp-23.97%-58.92pp34.95%-8.53pp43.48%
EPS0.03-25.0%0.040.00-100.0%0.02+0.0%0.02-80.0%0.10+100.0%0.05-54.5%0.11

Corporate Events

Board MeetingSYMBIOX
2026
13Nov

Board Meeting

The Board of Directors will consider and approve the Unaudit…

BSE Filing ↗
Board MeetingSYMBIOX
2026
28Sep

Board Meeting

The 47th Annual General Meeting of the Company will be held …

BSE Filing ↗
Board MeetingSYMBIOX
2026
26Aug

Board Meeting

The Board of Directors will consider and approve the Directo…

BSE Filing ↗
Board MeetingSYMBIOX
2026
12Aug

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing ↗
Board MeetingSYMBIOX
2024
12Nov

Board Meeting

Consider and approve Unaudited Financial Result for Quarter …

BSE Filing ↗
Board MeetingSYMBIOX
2024
2Sep

Board Meeting

Consider and approve the Director Report and annexure thereo…

BSE Filing ↗
Board MeetingSYMBIOX
2024
14Aug

Board Meeting

Consider and approve Unaudited Financial Result for quarter …

BSE Filing ↗